EN
抗体药类似物
Research Grade Bebtelovimab
All
TD-VK565196_1.jpg
  • CatalogTD-VK565196
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsLY-CoV1404,LY3853113
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Bebtelovimab


Catalog No. TD-VK565196
Species reactivity SARS-CoV-2 (2019-nCoV)
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1, lambda2
Expression system Mammalian Cells
Clonality Monoclonal
Target Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2, Receptor-Binding Domain, RBD
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P0DTC2-2
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names LY-CoV1404,LY3853113
Background Bebtelovimab a humanized IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19. Bebtelovimab potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-VK565196_1.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Bebtelovimab.